Lexeo Therapeutics, Inc. (LXEO)

SEC filing

Lexeo Therapeutics, Inc.

LXEO · CIK 1907108

4 · Aug 19, 2026 · Chief Financial Officer Tamayo Louis Edward sold 4,117 shares at $4.91/share ($20,203)

Chief Financial Officer Tamayo Louis Edward sold 4,117 shares at $4.91/share ($20,203)

xslF345X06/form4-08192026_050809.xml

xslF345X06/form4-08192026_050809.xmlSEC.gov

Graphics and non-inline formats (not embedded below).